IMO pretty weak capital raise. It appears market has NO Confidence with the management and/or the new asset. For the time being I'll just put them on my watch list for the next 4 months and wait on the sidelines.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ASX Market Open: Aussie investors to power past concerns raised by Trump's tariff threats | November 27, 2024